This is NOT the formal application. Please apply through the USC application portal found on this page to be considered for this position: https://provost.sma.usc.edu/prog/usc_alfred_e_mann_school_of_pharmacy_and_pharmaceutical_sciences_fellowship_2026-2027/
Applications submitted through PPS will only be used to contact final-round candidates for interviews at ASHP Midyear Meeting.
Dear Prospective Fellowship Candidate,
The University of Southern California, USC Mann School of Pharmacy and Pharmaceutical Sciences and Gilead Sciences, Inc. are proud to offer two 2-year Patient Safety fellowship positions to recent doctoral graduates (PharmD, MD, PhD, or equivalent doctorate degree) interested in pursuing a career in the pharmaceutical industry and Patient Safety. Patient Safety is a crucial part of drug development and commercialization to predict, mitigate, manage, and communicate the risks of Gilead's medicines so patients can derive the maximum benefit. The fellow will be an integral part of the team and will work closely with our PS Scientists, Physicians, and Global Safety Leads on site at Gilead Headquarters located in Foster City, California. Of note, this role may involve occasional travel for industry conferences and meetings to enhance the fellows’ professional network and experience.
Duration: 2 years (July 1, 2026 – June 30, 2028)
Positions Available: 2
Location: Foster City, California
Patient Safety Fellowship Activities:
Pharmacovigilance: Learn about US Food and Drug Administration (FDA) and European Medicines Agency (EMA) regulations related to pharmacovigilance practices including preparation of aggregate reports such as Development Safety Update Reports (DSURs) and PBRER (Periodic Benefit Risk Evaluation Reports) and development and maintenance of risk management plans (RMPs).
Conduct signal detection and evaluation activities for assigned products in collaboration with the Patient Safety Physician and Scientist as part of the continuous benefit-risk evaluation throughout the product lifecycle including analyzing safety data and contributing to safety reviews of adverse events using various data sources.
Participate in safety surveillance of clinical trial data and postmarketing data, contribute to activities related to regulatory filings, New Drug Applications [NDAs], Biologics License Applications [BLAs]), and responses to safety queries from regulatory agencies.
The fellow will work 1 year each in the Oncology and Virology therapeutic areas as well as learn about other areas that build foundational knowledge such pharmacogivilance regulations, how safety reports are processed and provided to health authorities.
Safety in Clinical Trials: Support the review of clinical trial documents including protocols, Investigator’s Brochures, clinical study reports, and informed consent forms.
Support the review and monitoring of clinical trial safety data to define the benefit- risk profile of Gilead products at different stages of drug development.
Cross-Functional Collaboration: Collaborate with colleagues from other departments such as Regulatory Affairs, Clinical Development, Medical Affairs, Clinical Pharmacology, and Nonclinical Safety & Pathobiology to learn about how these functions interact with Patient Safety.
USC Graduate Coursework: Fellows may complete graduate coursework at the University of Southern California with the opportunity to pursue a Graduate Certificate in a variety of fields.
Leadership & Career Development: Fellows will have opportunities for leadership, teaching, and professional growth, including mentoring PharmD students and engaging in professional development activities such as goal setting, strengths identification/assessments, advising, coaching, and mentoring at USC.
Minimum Application Requirements:
The candidate must be a US citizen/permanent resident and have completed a PharmD, MD, PhD, or equivalent doctorate degree from an accredited college or university within five years of initial appointment and a minimum doctoral program GPA of 3.0, have good oral and written communication skills, ethics, professionalism, leadership, and an interest in the biopharmaceutical industry.
Interview Requests: Interviews are limited and will be scheduled on a rolling basis. For early consideration, please submit your application, including your CV and a letter of intent, by November 30, 2025 and at the following link: https://provost.sma.usc.edu/prog/usc_alfred_e_mann_school_of_pharmacy_and_pharmaceutical_sciences_fellowship_2026-2027/
Final interviews may be conducted virtually, at the ASHP Midyear Clinical Meeting, or on-site at Gilead headquarters located in Foster City, CA.
Please follow the document conventions listed below:
CV
Document type: PDF
Document name: Last Name_First Name_CV.pdf
Letter of intent
Document type: PDF
Document name: Last Name_First Name_Letter_ Program of Interest.pdf
The University of Southern California is one of the world’s leading private research universities. An anchor institution in Los Angeles, a global center for arts, technology and international trade, USC enrolls more international students than any other U.S. university and offers extensive opportunities for internships and study abroad. With a strong tradition of integrating liberal and professional education, USC fosters a vibrant culture of public service and encourages students to cross academic as well as geographic boundaries in their pursuit of knowledge.